2013 FDA Approval
After an extensive on-site review, the FDA has determined that GRAM meets all requirements for production of parenteral drug products, both aseptically filled and terminally sterilized.
The Latest From Grand River Aseptic Manufacturing
News
Annex 1 is Not the Ceiling for Compliance; It is the Foundation
Navigating Evolving Regulatory Expectations and Annex 1 in Sterile Manufacturing: Insights from GRAM’s Director, QA and Regulatory Affairs As the...
News
Grand River Aseptic Manufacturing Announces $100 Million Investment in Sterile Manufacturing Capabilities
The company is enhancing its U.S. sterile fill-finish contract manufacturing services to meet growing industry demand for prefilled syringes and...
News
CEO Insights and Trends: The Future of the Sterile Filling CDMO Industry
Denis Johnson, CEO, explores developments in the CDMO sector and reveals how GRAM is gearing up for its latest phase...